Pure Global
NCT06241612

Individualized Elective Neck Irradiation in NPC Patients

Individualized Elective Neck Irradiation Based on the Lymph Node Metastasis Pattern in NPC Patients
Sun Yat-sen University·Phase 3·ClinicalTrials.gov·radiationNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Nasopharyngeal Carcinoma
Drug/Device/Intervention
Individualized Elective Neck Irradiation
Study type
Interventional
Intervention type
radiation
Sponsor & location
Primary sponsor
Sun Yat-sen University
Timeline & enrollment
Phase
Phase 3
Start date
Mar 01, 2024
End date
Mar 01, 2031
Enrollment
550 participants
Primary outcome

Regional relapse-free survival

Summary

To evaluate whether individualized elective neck irradiation for nasopharyngeal carcinoma
 based on the vertebral level of metastatic lymph nodes can reduce the incidence of
 radiation-related adverse effects and improve patients' quality of life，without reducing
 survival.

ICD-10 classifications
Malignant neoplasm of nasopharynxMalignant neoplasm: Nasopharynx, unspecifiedMalignant neoplasm: Overlapping lesion of nasopharynxBenign neoplasm: NasopharynxMalignant neoplasm: Posterior wall of nasopharynx
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06241612
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06241612 through Pure Global AI's free database. This Phase 3 trial is sponsored by Sun Yat-sen University and is currently Not yet recruiting. The study focuses on Nasopharyngeal Carcinoma. Target enrollment is 550 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.